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Syngap1 haploinsufficiency is a common cause of
sporadic intellectual disability. Syngap1 mutations
disrupt developing pyramidal neurons, although it
remains unclear if this process contributes to cogni-
tive abnormalities. Here, we found that haploinsuffi-
ciency restricted to forebrain glutamatergic neurons
was sufficient to disrupt cognition and removing
mutations from this population prevented cognitive
abnormalities. In contrast, manipulating Syngap1
function in GABAergic neurons had no effect on
cognition, excitability, or neurotransmission, high-
lighting the specificity of Syngap1 mutations within
forebrain excitatory neurons. Interestingly, cognitive
abnormalities were reliably predicted by the emer-
gence of enhanced excitatory synaptic function
in mature superficial cortical pyramidal cells, which
was a neurophysiological disruption caused by Syn-
gap1 dysfunction in developing, but not adult, fore-
brain neurons. We conclude that reduced cognition
in Syngap1 mutants is caused by isolated damage
to developing forebrain glutamatergic neurons. This
damage triggers secondary disruptions to synaptic
homeostasis inmature cortical pyramidal cells,which
perpetuates brain dysfunction into adulthood.
INTRODUCTION
Intellectual disability (ID) is characterized by low IQ and behav-
ioral deficits, reaching a prevalence of 1%–3% worldwide. This
is a devastating brain disorder in whichmany patients are unable
to care for themselves, placing a tremendous emotional and
economic burden on families and society (Centers for Disease
Control and Prevention, 2004; Doran et al., 2012). SYNGAP1/
Syngap1 (now referred to as Syngap1 for simplicity) is amongthe most commonly mutated genes in sporadic ID. De novo
autosomal dominant mutations in Syngap1 that produce hap-
loinsufficiency account for 2%–8% of these cases, and the ma-
jority of patients have more severe forms of ID (Berryer et al.,
2013; de Ligt et al., 2012; Hamdan et al., 2009, 2011a, 2011b;
Krepischi et al., 2010; Rauch et al., 2012). Considering the rela-
tively high prevalence of sporadic ID in the population, the sur-
prising frequency of pathogenic Syngap1 mutations in enriched
patient populations suggest that there are tens-of-thousands of
undocumented individuals carrying these mutations. Affected
individuals also have a high incidence of childhood seizures
and autism spectrum disorder. Syngap1 haploinsufficiency has
been causally linked to epileptic encephalopathy, a devastating
and often fatal form of childhood epilepsy that dramatically im-
pairs cognitive development (Carvill et al., 2013). These recently
identified patients with epileptic encephalopathy and Syngap1
mutations also share ID and autism spectrum disorder comor-
bidities. Thus, proper Syngap1 gene dosage is essential for the
normal development of human cognition and appears to modify
important aspects of neural excitability and sociability.
The Syngap1 heterozygous knockout mouse line (Syngap1+/)
has emerged as a robust model to understand the patho-neuro-
biology that underlies reduced cognitive ability and neural hyper-
excitability in sporadic ID and epilepsy. Syngap1+/mice display
significant cognitive, emotional, and social abnormalities, which
supports the idea that inactivating mutations of this gene directly
cause cognitive impairment (Berryer et al., 2013; Guo et al.,
2009; Komiyama et al., 2002; Muhia et al., 2010). Reduced Syn-
gap1 function in development accelerates the maturation of
excitatory synaptic function in forebrain pyramidal cells (Clement
et al., 2012, 2013), suggesting that damage to developing gluta-
matergic neurons may contribute to cognitive abnormalities in
Syngap1mutants. However, a causal link between cognitive de-
fects in Syngap1 haploinsufficiency and developing glutamater-
gic neurons has not been shown. The change in glutamatergic
neuron synapse development could be an inconsequential sec-
ondary outcome arising from dysfunction in other cell subtypes.
Indeed, elegant studies in models of syndromic neurodevelop-
mental disorders (NDDs) have shown that a single pathogenicNeuron 82, 1317–1333, June 18, 2014 ª2014 Elsevier Inc. 1317
Figure 1. Altered EEG Activity, Reduced Seizure Threshold, and Cortical Hyperexcitability in Adult Syngap1+/– Mice
(A) Representative cortical EEG traces from chronically implanted, behaving Syngap1 +/ conventional mutant mice (n = 3) reveal frequent generalized sharp
epileptiform discharges (upper left), and occasionally brief (<1 s) or prolonged (>10 s) seizures with a myoclonic jerk or little behavioral accompaniment during
video monitoring (lower three traces). WT mice (n = 2) showed no evidence of hyperactive EEG spike discharges or seizures (top right). Electrodes record
bilaterally from temporal and parietal cortices over left and right hemispheres in upper traces, and from left parietal cortex in lower seizure traces.
(B) Reduced flurothyl seizure threshold in both Syngap1+/ and Syngap1+/lx-st mutant mice (red bars) compared to WT controls (blue bars). Time (in seconds)
taken to reach three separate events, first clonus (1st C), tonic-clonic (T/C), and total hindlimb extension (THE), during the course of the procedure weremeasured
(legend continued on next page)
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Cause of Cognitive Dysfunction in Syngap1 Mutantsmutation can affect the function of various cell types in the brain
(Chao et al., 2010; Lioy et al., 2011). Furthermore, these studies
demonstrate that multiple cell types are sufficient to drive cogni-
tive, behavioral, and/or electrophysiological abnormalities in the
CNS of NDDmodels. Thus, it remains unclear if altered develop-
ment of glutamatergic neurons contributes importantly to cogni-
tive deficits in Syngap1 mutants. In addition, it is not known if
other neuronal subtypes are also sufficient to drive cognitive ab-
normalities in these mice.
Complete restoration ofSyngap1 protein expression (SynGAP)
in adultmutants has nodetectable benefit on behavior andcogni-
tion, demonstrating thatSyngap1 haploinsufficiency is a disorder
of brain development (Clement et al., 2012). Interestingly, all
currently reported baseline neurophysiological abnormalities
observed in young glutamatergic neurons of Syngap1+/ mice,
such as enhanced excitatory synaptic transmission, are tran-
siently expressed during development (Clement et al., 2012,
2013). Thus, it also remains unclear how Syngap1 mutations in
development affect adult brain function. Indeed, because the
abnormal cognition persists throughout life, these findings sug-
gest that there are undiscovered neurophysiological abnormal-
ities in adult mice that arise from abnormal brain development
and reflect abnormal cognition. To explore causal links between
Syngap1dysfunction in developing glutamatergic neurons, stabi-
lized changes to adult brain function, and altered cognitive ability,
we combined cell-type specific and inducible conditional mouse
lines with behavioral endophenotyping and electrophysiology.
Using this approach, we found that germline Syngap1mutations
induced a persistent form of stabilized cortical hyperexcitability
that lasted into adulthood. Remarkably, this was caused exclu-
sively by abnormal function of developing glutamatergic neurons
located in the forebrain, because no phenotypic role for Syngap1
in neurons that release GABA was apparent. Unexpectedly, ab-
normalities indevelopingglutamatergicneuronscausedanemer-
gent, secondary disruption to glutamatergic synaptic strength
in adult neurons that reliably predicted the presence of reduced
cognition. These data demonstrate that altered neurodevelop-
mental processes in a single sensitive cell type can perpetuate
brain dysfunction into adulthood by altering excitatory/inhibitory
(E/I) balance through a disruption of synaptic homeostasis.
RESULTS
Cortical Hyperexcitability and Progressively Worsening
Superficial Pyramidal Cell E/I Balance in Adult Syngap1
Mutants
We sought to investigate how altered brain development in
Syngap1+/ mice disrupts the function of the adult CNS. First,and plotted in the y axis. Syngap1+/: RMANOVA; genotype effect, F(1,19) =
Syngap1+/lx-st: RMANOVA; genotype effect, F(1,24) = 5.47,p = 0.028; genotype x
(C) Syngap1+/mPFC slices exhibit higher evoked excitability compared to WT c
data from VSD imaging of evoked circuit activity in response to electrical stimulati
The color scale codes VSD signal amplitude expressed as SD multiples above
based response analysis (see Experimental Procedures). The y axis shows the sum
electrical stimulation. Student’s t test: 50 mA, n = 7WT, n = 7mutant, t(12) = 1.44, p
n = 7 mutant, t(13) = 2.59, p = 0.022.
WT (+/+), blue; mutants (+/), red for all bar graphs. Error bars represent SEM. *we performed electroencephalography (EEG) paired with video
monitoring to examine spontaneous cortical activity in mutants
(Figure 1A), which revealed frequent and widespread cortical
discharges of high amplitude in mature Syngap1+/ mice
(>12 weeks), but not in wild-type (WT) littermates. These epilep-
tiform discharges were intermittent, ranging in frequency from 1
to 681/hour (average 81/hr). However, they did not coincide with
any significant motor events. Interestingly, cortical generalized
seizures with myoclonic features have also been reported in
patients with Syngap1 loss of function mutations (Berryer et al.,
2013) and with lower cognitive ability (Carvill et al., 2013). We
reasoned that cortical hyperexcitability might reflect a reduced
seizure threshold in adult mutants. A flurothyl-induced activation
paradigm (Clement et al., 2012) revealed a clear reduction in
seizure threshold in two distinct Syngap1 haploinsufficient
mouse lines (Figure 1B). To determine if network hyperexcit-
ability in mutants was preserved in ex vivo preparations, we
performed fast voltage-sensitive dye (VSD) imaging in acute
brain slices derived from adult Syngap1 animals. Slices from
adult Syngap1+/ mice resulted in significantly larger signals
throughout the cortex when compared to slices derived from
WT littermates (Figure 1C).
Because SynGAP is a potent regulator of glutamatergic syn-
apse function (Clement et al., 2012, 2013; Rumbaugh et al.,
2006), we hypothesized that elevated unitary synaptic strength
in cortical pyramidal neurons contributes to slice hyperexcitabil-
ity. To test this idea, we measured miniature excitatory postsyn-
aptic currents (mEPSCs) from medial prefrontal cortex (mPFC)
layer 2/3 (L2/3) neurons in acute slices prepared from WT or
Syngap1+/ mice (Figures 2A and 2B). Interestingly, mEPSCs
were normal in young cortical neurons (Figures 2C–2E). How-
ever, by adulthood, there was an increase in both the amplitude
and frequency of the events (Figures 2F–2H). We also patched
neurons in slices derived from the Syngap1+/lx-st mice. Neurons
from this mouse line also exhibited enhanced mEPSC function
in Layer 2/3 neurons (Figures 2I–K). To determine if the E/I ratio
was disrupted in L2/3 pyramidal neurons, we acquired miniature
inhibitory postsynaptic currents (mIPSCs) from neurons in slices
derived from adult Syngap1+/ or WT littermates. There was a
reduction in mIPSC amplitude in conventional Syngap1+/
mice (Figure 2L), but no change in mIPSC properties in the
Syngap1+/lx-st mice (Figure 2M). However, because excitatory
unitary synaptic strength was increased in both models relative
to GABAergic neuron synaptic transmission, this is consistent
with an elevated E/I ratio in mature mPFC cortical neurons in
mice with Syngap1 haploinsufficiency. Furthermore, L2/3 neu-
rons were hyperexcitable in response to evoked neurotrans-
mitter release (Figure S1 available online). We next measured20.46, p = 0.00023; genotype x event interaction, F(2, 38) = 0.99, p = 0.38.
event interaction, F(2,48) = 6.46, p = 0.0033.
ontrol slices when examined with fast VSD imaging. (Top) Example time series
on of 200 mA at 1 ms. All image frames were averaged over eight separate trials.
the mean baseline. Warmer colors indicate greater excitation. (Bottom) Pixel-
med response (in the SDmultiple units) across the defined response frames to
= 0.18; 100 mA, n = 8WT, n = 8mutant, t(14) = 1.78, p = 0.096; 200 mA, n = 8WT,
p < 0.05.
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Cause of Cognitive Dysfunction in Syngap1 Mutantselectrically isolated excitatory and inhibitory evoked responses
from individual L2/3 pyramidal cells in mPFC slices from adult
WT and Syngap1mutants (Figures S1A–S1C). There was no sig-
nificant effect of peak excitatory responses in the basal pathway,
although there was an increase in the slope of the input/output
curve (Figures S1D and S1E). Importantly, evoked E/I balance
was significantly shifted in both pathways (Figures S1L and
S1M), which is consistent with ourmEPSC/mIPSC data and sup-
ports the conclusion that L2/3 neurons are hyperexcitable in
Syngap1 mutants.
To this point, our measurements have been restricted to syn-
aptic properties of L2/3 pyramidal neurons. However, there are
other possible cellular causes of network hyperexcitability,
such as alterations to the function of distinct classes of local
inhibitory neurons in the superficial cortex (Figure 2B). Therefore,
we probed Syngap1 mutants for changes in two major subtypes
of cortical GABAergic neurons. To label Parvalbumin-positive
(PV+) neurons in the Syngap1+/ background, we crossed
Syngap1+/mice that also contained the Ai9 Cre-dependent re-
porter allele (Madisen et al., 2010) with PV+-ires-Cre driver mice
(Hippenmeyer et al., 2005; Figure 3A). tdTomato+ (TD+) neurons
from both genotypes exhibited properties consistent with those
of PV+ neurons (Table S1; Helm et al., 2013; Lazarus and Huang,
2011). There were no genotype differences in firing properties of
these cells at PND 14 (Figure 3B). In contrast, there was a sub-
stantial decrease in firing rate in PV+ neurons in Syngap1+/
mice by 6 weeks of age (Figure 3C), which was consistent with
cortical hyperexcitability. Interestingly, by 9 weeks of age, the
difference between genotypes was no longer significant (Fig-
ure 3D). We next measured unitary synaptic strength onto PV+
neurons in mature animals. Overall, there was a small reduction
in mEPSC amplitude in PV+ neurons (Figure 3E). However, this
was only present in males (two-way ANOVA for PV+ mEPSC
amplitude: genotype effect, F(1,61) = 6.00, p = 0.02; sex effect
F(1,61) = 5.01, p = 0.03; genotype*sex F(1,61) = 4.72, p = 0.03). InFigure 2. The Gradual Development of E/I Imbalance in L2/3 Pyramida
(A) A coronal section through the mouse brain illustrating where in the mPFC targ
prelimbic cortex; IL, infralimbic cortex.
(B) A high-magnification differential interference contrast image of example L2/3
(C) Example recordings of mEPSC events in PND14 Syngap1+/ animals. Scale
(D) Bar graph and cumulative percentage plots show normal mEPSC amplitud
t(27) = 0.40, p = 0.69; two sample K-S test on cumulative percentage distributio
(E) Bar graph and cumulative percentage plots show normal mEPSC frequenc
t(27) = 1.66, p = 0.11; two sample K-S test on cumulative percentage distributio
(F) Example recordings of mEPSC events in >9-week-old Syngap1+/ animals. S
(G) Bar graph and cumulative percentage plots show increased mEPSC amplitud
t(21) = 3.61, p = 0.0016; two sample K-S test on cumulative percentage distribu
(H) Bar graph and cumulative percentage plots show increased mEPSC frequenc
t(21) = 3.02, p = 0.0065; two sample K-S test on cumulative percentage distribu
(I) Example recordings of mEPSC events in >9-week-old Syngap1+/lx-st animals.
(J) Bar graph and cumulative percentage plots show increased mEPSC amplit
t(21) = 2.57, p = 0.018; two sample K-S test on cumulative percentage distributi
(K) Bar graph and cumulative percentage plots show slightly increased mEPSC fre
t(21) = 1.50,p = 0.15; two sample K-S test on cumulative percentage distribution
(L) Bar graphs and example recordings show reduced mIPSC amplitude and norm
n = 12 neurons +/; t(22) = 2.57, p = 0.02 for mIPSC amplitude; t(22) = 0.88, p =
(M) Bar graphs and example recordings show normal mIPSC amplitude and norm
n = 7 neurons +/; t(14) = 0.48, p = 0.64 for mIPSC amplitude; t(14) = 0.40, p =
WT(+/+), blue; mutants(+/), red for all bar graphs. Error bars represent SEM. *pcontrast, there was no sex-genotype interaction in L2/3
pyramidal cell mEPSC properties (two-way ANOVA for L2/3
neuron mEPSC amplitude: genotype effect, F(1,102) = 11.22,
p = 0.0011; sex effect, F(1,102) = 6.24, p = 0.014;genotype*sex,
F(1,102) = 0.054, p = 0.81. Two-way ANOVA for L2/3 neuron
mEPSC frequency: genotype effect, F(1,102) = 17.42, p =
0.0000629; sex effect, F(1,102) = 0.003, p = 0.96;genotype*sex,
F(1,102) = 0.35, p = 0.55; combined data). Thus, PV+ neurons
may contribute to hyperexcitability at some stages of develop-
ment, but individual changes in cellular and synaptic properties
in these neurons do not stabilize in the fully mature CNS.
We next probed for potential cellular disruptions in somato-
statin-positive (SST+) local inhibitory neurons. Surprisingly, there
were no genotype effects in any major cellular or synaptic
measures in adult (>9 weeks) SST+ neurons (Figures 3F–3I;
Table S1). There was a robust increase in action potential width
of these neurons. However, this is a relatively minor physiolog-
ical disruption with an unknown impact on network function
(Table S1). Together, these data indicate that critical measures
of inhibition are largely unaffected in the fully mature superficial
cortex of Syngap1 mutants.
E/I Imbalance Predicts Cognitive Abnormalities and
Results from Syngap1 Dysfunction Exclusively in
Glutamatergic Neurons of the Developing, but Not
Mature, Forebrain
Increased pyramidal cell excitatory synaptic strength appeared
to be a reliable signature of altered neurophysiological function
in themutant cortex, suggesting thatSyngap1 haploinsufficiency
is principally a disease of altered glutamatergic neuron func-
tion. However, an abundance of SynGAP protein is found in
both glutamatergic and GABAergic neurons in various cortical
and subcortical areas of the brain, including heavy expression
in the striatum (Moon et al., 2008; Porter et al., 2005; Zhang
et al., 1999). Therefore, we explored the behavioral contributionl Neurons in Syngap1+/– Mice
eted whole-cell recordings were performed. Cg1, cingulated cortex area 1; PL,
neurons and simplified diagram of L2/3 circuitry.
bar represents 20 pA, 100 ms.
e in PND14 Syngap1+/ animals (n = 15 neurons +/+, n = 14 neurons +/;
n Z = 1.17, p = 0.13).
y in PND14 Syngap1+/ animals (n = 15 neurons +/+, n = 14 neurons +/;
n Z = 1.14, p = 0.15).
cale bar represents 20 pA, 100 ms.
e in >9-week-old Syngap1+/ animals (n = 12 neurons +/+, n = 11 neurons +/;
tion Z = 4.34, p < 0.001).
y in >9-week-old Syngap1+/ animals (n = 12 neurons +/+, n = 11 neurons +/;
tion Z = 3.99, p < 0.001).
Scale bar represents 20 pA, 100 ms.
ude in >9-week-old +/lx-st animals (n = 9 neurons +/+, n = 14 neurons +/;
on Z = 5.42, p < 0.001).
quency in >9-week-old +/lx-st animals (n = 9 neurons +/+, n = 14 neurons +/;
Z = 3.53, p < 0.001).
al mIPSC frequency in >9-week-old Syngap1+/ animals. (n = 12 neurons +/+,
0.39 for mIPSC frequency). Scale bar represents 30 pA, 100 ms.
al mIPSC frequency in >9-week-old Syngap1+/lx-st animals. (n = 9 neurons +/+,
0.70 for mIPSC frequency). Scale bar represents 20 pA, 100 ms.
< 0.05, **p < 0.01.
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Figure 3. Intrinsic and Synaptic Properties of L2/3 Inhibitory Neurons in Syngap1+/– Mice
(A) Experimental strategy to record from PV+ interneurons in L2/3. Images show differential interference contrast and fluorescent image of a PV+ interneuron.
(B) Normal current injection frequency response curve of PV+ interneurons at PND14. Example traces show firing responses of +/+ and +/ neurons in response
to 450 pA, 1 s long current injection (n = 11 neurons +/+, n = 11 neurons +/, repeated-measures ANOVA genotype effect F(1,20) = 0.11,p = 0.75, genoty-
pe*stimulus level F(6,120) = 0.11, p = 0.99). Scale bar represents 50 mV, 300 ms.
(C) Reduced current injection frequency response curve of PV+ interneurons at 6 weeks. Example traces show firing responses of +/+ and +/ neurons in
response to 450 pA, 1 s long current injection (n = 15 neurons +/+, n = 16 neurons +/, repeated-measures ANOVA genotype effect F(1,29) = 14.74, p = 0.001
genotype*stimulus level F(6,174) = 1.67, p = 0.13). Scale bar represents 50 mV, 300 ms.
(D) Normal current injection frequency response curve of PV+ interneurons at >9 weeks. Example traces show firing responses of +/+ and +/ neurons in
response to 450 pA, 1 s long current injection (n = 18 neurons +/+, n = 18 neurons +/, repeated-measures ANOVA genotype effect F(1,34) = 0.87, p = 0.36,
genotype*stimulus level F(6,204) = 0.864, p = 0.52). Scale bar represents 50 mV, 300 ms.
(E) Reduced excitatory input into PV+ interneurons. (Top) Example recordings of mEPSC events in PV+ interneurons. (Left) Bar graph and cumulative percentage
plots show reduced mEPSC amplitude in PV+ interneurons (n = 31 neurons +/+, n = 34 neurons +/; t(63) = 2.63, p = 0.01; two sample K-S test on cumulative
percentage distribution Z = 2.15, p = 0.0002). (Right) Bar graph and cumulative percentage plots show normal mEPSC frequency in PV+ interneurons (n = 31
neurons +/+, n = 34 neurons +/; t(63) = 0.14, p = 0.88; two sample K-S test on cumulative percentage distribution; Z = 0.58, p = 0.89). Scale bar represents 15 pA,
125 ms.
(F) Experimental strategy to record from somatostatin-positive (SST+) interneurons in L2/3. Pictures show differential interference contrast and fluorescent image
of a SST+ interneuron.
(G) Normal current injection frequency response curve of SST+ interneurons at >9 weeks. Example traces show firing responses of +/+ and +/ neurons in
response to 120 pA, 1 s long current injection (n = 23 neurons +/+, n = 21 neurons +/, repeated-measures ANOVA genotype effect F(1,42) = 1.77, p = 0.19,
genotype*stimulus level F(6,252) = 1.02, p = 0.41). Scale bar represents 50 mV, 300 ms.
(H) Normal excitatory input into SST+ interneurons. (Top) Example recordings of mEPSC events in SST+ interneurons. (Left) Bar graph and cumulative percentage
plots show normal mEPSC amplitude in SST+ interneurons (n = 12 neurons +/+, n = 15 neurons +/; t(25) = 1.19, p = 0.24; two sample K-S test on cumulative
percentage distribution Z = 1.25, p = 0.087). (Right) Bar graph and cumulative percentage plots show normal mEPSC frequency in SST+ interneurons (n = 12
neurons +/+, n = 15 neurons +/; t(25) = 0.15, p = 0.88; two sample K-S test on cumulative percentage distribution Z = 0.77, p = 0.59). Scale bar represents 15 pA,
125 ms.
(I) Normal inhibitory input into SST+ interneurons. (Top) Example recordings of mIPSC events in SST+ interneurons. (Left) Bar graph and cumulative percentage
plots show normal mIPSC amplitude in SST+ interneurons (n = 34 neurons +/+, n = 22 neurons +/; t(54) = 0.38, p = 0.71; two sample K-S test on cumulative
(legend continued on next page)
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Cause of Cognitive Dysfunction in Syngap1 Mutantsof in vivo Syngap1 dysfunction in distinct cellular populations. In
the first set of experiments, we crossed the conditional knockout
line (Syngap1+/fl; Clement et al., 2012) with EMX1-ires-Cre driver
mice (Gorski et al., 2002). This mouse driver line induces Cre-
mediated recombination in forebrain glutamatergic neurons
and glia (Figure 4A). Importantly, SynGAP is a neuron-enriched
gene (Chen et al., 1998; Kim et al., 1998; Kozlenkov et al.,
2014) with no observable expression in glial cells (G.R., unpub-
lished data), indicating that this Cre driver line is an excellent
tool to determine if Syngap1 genetic damage in developing
cortical pyramidal cells is sufficient to disrupt cognitive develop-
ment. SynGAP levels were reduced in the hippocampus, but not
striatum, in extracts taken from Emx1-Cre;Syngap1+/fl mice
(Figure 4B). Importantly, a reduction in SynGAP protein levels
was also observed in the frontal cortex (Figure S2). The behav-
iors displayed by Emx1-Cre;Syngap1+/flmicewere indistinguish-
able from those of conventional Syngap1 mutants. Relative to
WT littermates, EMX1-Cre;Syngap1+/fl mice spent more time in
the open arm of the elevated plus maze (Figure 4C), were hyper-
active in the open field (Figure 4D), and failed to spontaneously
alternate (Figure 4E). Conventional Syngap1 Het mice had
deficits in remote (30 day old) fear memory (Figure S3), allowing
us to include an additional measure of cognition in the behav-
ioral battery. Again, similar to conventional Syngap1 mutants,
Emx1-Cre;Syngap1+/fl mice exhibited a remote memory deficit
(Figure 4F). We next assessed adult seizure threshold. Consis-
tent with the behavioral endophenotyping results, the Emx1-
Cre;Syngap1+/fl mice also had a reduced seizure threshold
(Figure 4G) that was qualitatively similar to conventional germline
Syngap1 mutants (Figure 1B).
To induce haploinsufficiency in developing GABAergic neu-
rons, we next crossed Syngap1 conditional knockout mice to
Gad2-ires-Cre driver mice (Taniguchi et al., 2011; Figure 4H).
A reduction in SynGAP expression in the striatum, but not hippo-
campus, confirmed haploinsufficiency in the target neuronal
population (Figure 4I). Unexpectedly, SynGAP levels in the
hippocampus of Gad2-Cre mice increased slightly. Therefore,
we also probed SynGAP expression levels in the frontal cortex
of Gad2-Cre;Syngap1+/fl mice. There was no change in SynGAP
expression (Figure S2), which is consistent with low expression
of SynGAP in cortical GABAergic neurons (Zhang et al., 1999).
Surprisingly, despite SynGAP expression being reduced
in GABAergic neurons in the CNS, including the striatum,
there were no changes in behavior or seizure threshold (Figures
4J–4N).
If disruptions to forebrain glutamatergic neurons are the
primary driver of the endophenotype in Syngap1+/ mice, then
rescuing the mutation exclusively in this population should pro-
tect animals from developing behavioral abnormalities. To test
this, we crossed EMX1- or GAD2-ires-Cre drivermice to theSyn-
gap1 conditional rescue line (Syngap1+/lx-st; Clement et al., 2012;
Figures 5A and 5G). Remarkably, reversing the pathogenicpercentage distribution Z = 1.15, p = 0.14). (Right) Bar graph and cumulative p
neurons +/+, n = 22 neurons +/; t(54) = 0.15, p = 0.88; two sample K-S test on
15 pA, 125 ms.
WT(+/+), blue; mutants(+/), red for all bar graphs. Error bars represent SEM. *pmutations only in forebrain glutamatergic neurons (Emx1-
Cre;Syngap1+/lx-st mice) was sufficient to protect animals from
developing major behavioral impairments, including altered anx-
iety and risk-taking, reduced working memory, and disrupted
remote contextual memory (Figures 5B–5F). Interestingly,
Emx1-Cre;Syngap1+/lx-st mice were still hyperactive in the open
field (Figure 5C) and exhibited a reduced seizure threshold
(Figure 5F), suggesting that extracortical neurons contribute to
these abnormalities. This notion was supported by the observa-
tion that seizure threshold was rescued after global reversal of
Syngap1 haploinsufficiency (Figure S4). In a complementary
set of experiments, reversal of a pathogenic Syngap1 mutation
in GABAergic neurons located throughout the entire CNS
(Gad2-Cre;Syngap1+/lx-st) provided no improvement to core
Syngap1 behavioral abnormalities (Figure 5H–5L).
Enhanced excitatory synaptic function in mature pyramidal
neurons is present in both of our models of Syngap1 haploinsuf-
ficiency (Figures 2F–2K). These data suggested that this neuro-
physiological abnormality is predictive of cognitive dysfunction
and/or hyperexcitability in Syngap1 mutants. To test this,
we patch-clamped L2/3 neurons in mPFC acute slices taken
from EMX1- and Gad2-ires-Cre mice crossed to each of our
conditional Syngap1 mutant lines. Both Emx1-Cre;Syngap1+/fl
(forebrain glutamatergic conditional disruption) and Gad2-
Cre;Syngap1+/lx-st (GABAergic neuron rescue) animals, which
were offspring that had reduced cognition and altered seizure
thresholds (Figures 4C–4G and 5G–5L), had enhanced excit-
atory synaptic strength in L2/3 mPFC pyramidal neurons
(Figures 6A–6C, 6J, and 6K). Interestingly, no changes to
pyramidal cell synaptic function were observed in either Gad2-
Cre;Syngap1+/fl (GABAergic conditional disruption) or Emx1-
Cre;Syngap1+/lx-st (forebrain glutamatergic neuron rescue)
lines (Figures 6D–6I), which were offspring that had normal
cognitive ability. We also tested the reliability of the reduced
mIPSCs observed in Syngap1+/ line as a signature of cognitive
ability, but found that neither Emx1-Cre;Syngap1+/fl nor Gad2-
Cre;Syngap1+/fl displayed reduced mIPSCs (Figure S5).
These data indicate that excitatory synaptic function in mature
superficial pyramidal neurons reliably predicts cognitive
ability, but not behavioral seizure threshold, in adult Syngap1
mutant mice.
In the next set of experiments, we further explored the relation-
ship between enhanced excitatory synaptic strength in L2/3 py-
ramidal neurons and cognitive disability in Syngap1mutants. To
do this, we induced global Syngap1 haploinsufficiency in mature
animals and then probed for physiological and behavioral
changes (Figure 7A). We first confirmed that tamoxifen injections
reduced SynGAP protein by 50% in the experimental animals
(Figure 7B), which is the level of expression observed in germline
heterozygous knockout mice (Clement et al., 2012). Despite the
conditional reduction of SynGAP protein in adulthood, mEPSC
amplitude or frequency were not changed (Figures 7C and 7D),ercentage plots show normal mIPSC frequency in SST+ interneurons (n = 34
cumulative percentage distribution Z = 1.26, p = 0.084). Scale bar represents
< 0.05.
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Cause of Cognitive Dysfunction in Syngap1 Mutantsconsistent with the idea that changes in adult L2/3 pyramidal
neuron excitatory synaptic function is a secondary consequence
of abnormal brain development. Based on our prior experiments
demonstrating the predictive value of this adult physiological
measure on cognitive ability, these data suggested that adult-
induced haploinsufficiency would have negligible effects on
cognition. Indeed, there was no change in core Syngap1 behav-
iors; open field locomotion (Figure 7E), elevated plus maze open
arm time (Figure 7F), the ability to spontaneous alternate in a
T-maze (Figure 7G), and remote memory (Figure 7H). However,
seizure threshold was reduced (Figures 7I and 7J), indicating
that this behavior is dissociable from cognitive dysfunction and
elevated cortical pyramidal cell excitatory synaptic function in
Syngap1 mutants.
Next, we explored the idea that stronger excitatory synaptic
function in L2/3 pyramidal cells was unrelated to reduced
SynGAP function in mature neurons, but instead is caused by
a complex molecular process that originates within developing
superficial pyramidal neurons. To test this, we exploited the abil-
ity to reverse pathogenic Syngap1mutations globally in the CNS
(Clement et al., 2012). As a proof of principle, however, we first
sought to discover a neurophysiological disruption in adult
Syngap1 mice that was sensitive to adult genetic reversal to
demonstrate the effectiveness of this mouse model as a tool to
differentiate developmental verses homeostatic consequences
of pathogenic Syngap1 mutations in brain cells. We chose to
focus on long-term potentiation (LTP) deficits because they are
well described in Syngap1 Hets (Kim et al., 2003; Komiyama
et al., 2002). Axonal excitability, release, and postsynaptic
responses were not affected by Syngap1 haploinsufficiency
(Figures 8A–8C), although stabilization of LTP was drastically
impaired in adult mutants (Figure 8D). Strikingly, LTP deficitsFigure 4. Syngap1 Haploinsufficiency in Glutamatergic, but Not GABA
(A) Experimental schematic depicts mouse breeding strategy and implementati
offspring of an Emx1-Cre x Syngap1+/fl cross.
(B) Hippocampal (HPC) and dorsal striatal (STR) tissue were dissected from Emx1
blot analysis of SynGAP protein levels normalized to b-tubulin after behavioral and
mutant, HPC: t(10) = 3.45; p = 0.0063; STR: t(10) = 0.051; p = 0.96.
(C–F) Emx1-Cre;Syngap1+/+ and Emx1-Cre;Syngap1+/fl mice were run in a behav
(OFT), an unforced discrete-two-trial spontaneous alternation task (SA), and a co
OF, and Ctxl FC tests. One-sample t test with 50%chance level as hypothetical me
WT, n = 18 mutant, t(32) = 5.44, p = 5.48E-06. OF - distance traveled (M): n = 12 W
p = 0.0011; n = 12 mutant: t(11) = 0.48; p = 0.64. Ctxl FC - % freezing: n = 7 WT
(G) Emx1-Cre: Syngap1+/+ and Emx1-Cre: Syngap1+/fl mice were subjected to a fl
first clonus (1st C), tonic-clonic (T/C), and total hindlimb extension (THE), during t
within each of the two cohorts. RMANOVA - genotype effect: F(1,32) = 10.79; p
(H) Experimental schematic depicts mouse breeding strategy and implementati
offspring of a Gad2-Cre x Syngap1+/fl cross.
(I) Hippocampal (HPC) and dorsal striatal (STR) tissue were dissected from Gad2
blot analysis of SynGAP protein levels normalized to b-tubulin after behavioral and
mutant, HPC: t(10) = 2.35; p = 0.040; STR: t(10) = 8.61; p = 0.00000612.
(J–M)Gad2-Cre: Syngap1+/+ and Gad2-Cre: Syngap1+/fl mice were run in a behav
(OFT), an unforced discrete-two-trial spontaneous alternation task (SA), and a co
OF, and Ctxl FC tests. One-sample t test with 50%chance level as hypothetical me
WT, n = 14mutant, t(28) = 1.30, p = 0.20. OF - distance traveled (M): n = 12WT, n =
n = 12 mutant, t(11) = 3.46; p = 0.0054. Ctxl FC - % freezing: n = 12 WT, n = 11
(N) Gad2-Cre: Syngap1+/+ and Gad2-Cre: Syngap1+/fl mice were subjected to a fl
first clonus (1st C), tonic-clonic (T/C), and total hindlimb extension (THE), during
RMANOVA - genotype effect-F(1,22) = 0.60; p = 0.45; genotype x event interact
WT, blue; mutants, red for all bar graphs. Error bars represent SEM. *p < 0.05, *were completely rescued by adult reversal of the pathogenicmu-
tation (Figure 8D). We next conducted fluorescence deconvolu-
tion tomography (Chen et al., 2007; Vogel-Ciernia et al., 2013) to
gain molecular insight into how pathogenic Syngap1 mutations
could disrupt the synaptic signaling steps thought to be involved
in LTP consolidation (Rex et al., 2009). Slices were collected
2 minutes after LTP-inducing theta bursts and immunostained
for PSD95 and Ras-GTP or phosphorylated ERK1/2 (Figure 8E).
Theta bursts doubled the number of Ras-GTP+ excitatory syn-
apses associated with high levels of Ras-GTP (p = 0.012,
t test, two-tails) in WT, but not mutants (p > 0.10; Figure 8F,
left). A similar pattern was found for p-ERK1/2; theta stimulation
caused a pronounced increase in the double-labeled contacts in
WT slices (p < 0.0001), but had no detectable effect in Hets (p >
0.95). Note that baseline levels of PSDs associated with high
concentrations of p-ERK were substantially and significantly
elevated relative to WTs in the mutants (p = 0.029, U-test; Fig-
ure 8F, right), indicating that reduced SynGAP protein in mature
spines derepresses resting levels of activated ERK1/2. In accor-
dance with the LTP results, conditional rescue of Syngap1 hap-
loinsufficiency returned the pERK1/2 response to theta bursts
to levels obtained in WT mice (control versus theta bursts: p =
0.002). We further investigated group differences by counting
the number of double-labeled synapses at various intensities
of pERK1/2 immunostaining, an analysis that included all
pERK-positive contacts. Theta bursts shifted the frequency dis-
tribution to the right in WT mice (p < 0.0001, two-way ANOVA;
Figure 8G), as expected if the LTP-inducing stimulation
increased the pool of activated kinase at a relatively small subset
of synapses. A similar effect was observed for slices prepared
from conditional rescue mice (p < 0.0001; Figure 8H), but was
altogether absent (p > 0.95) in Hets (Figure 8I).ergic, Neurons Mimics the Germline Mutant Endophenotype
on timing of a behavioral test battery and flurothyl-induced seizures for adult
-Cre: Syngap1+/+ and Emx1-Cre: Syngap1+/fl mice and processed for western
seizure paradigm testing. Normalized density - unpaired t test: n = 6 WT, n = 6
ioral battery consisting of an elevated plus maze task (EPM), an open field test
ntextual fear conditioning paradigm. Unpaired t tests were performed for EPM,
anwere performedwith each group for SA. EPM -%Open arm duration: n = 16
T, n = 12, t(22) = 5.18; p = 3.39E-05. SA - % alternation: n = 10 WT, t(9) = 4.71;
, n = 10 mutant, t(15) = 4.44, p = 0.00036.
urothyl-induced seizure paradigm. Time taken to reach three separate events,
he course of the procedure was measured and WT and HET groups compared
= 0.0025; genotype x event interaction: F(2,64) = 1.67; p = 0.20.
on timing of a behavioral test battery and flurothyl-induced seizures for adult
-Cre: Syngap1+/+ and Gad2-Cre: Syngap1+/fl mice and processed for western
seizure paradigm testing. Normalized density - unpaired t test: n = 6 WT, n = 6
ioral battery consisting of an elevated plus maze task (EPM), an open field test
ntextual fear conditioning paradigm. Unpaired t tests were performed for EPM,
anwere performedwith each group for SA. EPM -%Open arm duration: n = 16
12, t(22) = 0.20; p = 0.85. SA -% alternation: n = 12WT, t(11) = 3.45; p = 0.0055;
mutant, t(21) = 1.71, p = 0.1027.
urothyl-induced seizure paradigm. Time taken to reach three separate events,
the course of the procedure was measured and the two groups compared.
ion-F(2,44) = 2.42; p = 0.10.
*p < 0.01, ***p < 0.001.
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Figure 5. Reversal of Pathogenic Mutations in Forebrain Glutamatergic Neurons Is Sufficient to Rescue Cognitive and Emotional
Endophenotypes Present in Syngap1 Mutants
(A) Experimental schematic depicts mouse breeding strategy and implementation timing of a behavioral test battery and flurothyl-induced seizures for adult
offspring of an Emx1-Cre x Syngap1+/lx-st cross.
(B–E) Emx1-Cre: Syngap1+/+ and Emx1- Syngap1+/lx-st mice were run in a behavioral battery consisting of an elevated plus maze task (EPM), an open field test
(OFT), an unforced discrete two-trial spontaneous alternation task (SA), and a contextual fear conditioning paradigm. Unpaired t tests were performed for EPM,
OF, andCtxl FC tests. One-sample t test with 50%chance level as hypothetical meanwere performedwith each group for SA. EPM -%Open armduration: n = 15
WT, n = 15 mutant, t(28) = 0.21, p = 0.83. OF - distance traveled (M): n = 15 WT, n = 15, t(28) = 3.09; p = 0.0045. SA - % alternation: n = 15 WT, t(14) = 4.40;
p = 0.00050; n = 15 mutant: t(14) = 4.43; p = 0.00060. Ctxl FC - % freezing: n = 11 WT, n = 11 mutant, t(20) = 0.81, p = 0.42.
(F) Emx1-Cre: Syngap1+/+ and Emx1-Cre: Syngap1+/lx-st mice were subjected to a flurothyl-induced seizure paradigm. Time taken to reach three separate events,
first clonus (1st C), tonic-clonic (T/C), and total hindlimb extension (THE), during the course of the procedure was measured and the two groups compared.
RMANOVA - genotype effect: F(1,20) = 8.35; p = 0.0091; genotype x event interaction: F(2,40) = 0.22; p = 0.80.
(G) Experimental schematic depicts mouse breeding strategy and implementation timing of a behavioral test battery and flurothyl-induced seizures for adult
offspring of a Gad2-Cre x Syngap1+/lx-st cross.
(H–K)Gad2-Cre: Syngap1+/+ andGad2-Cre:Syngap1+/lx-st micewere run in a behavioral battery consisting of an elevated plusmaze task (EPM), an open field test
(OFT), an unforced discrete two-trial spontaneous alternation task (SA), and a contextual fear conditioning paradigm. Unpaired t tests were performed for EPM,
OF, and Ctxl FC tests. One-sample t test with 50% chance level as hypothetical mean was performedwith each group for SA. EPM -%Open arm duration: n = 17
WT, n = 16 mutant, t(31) = 6.83, p = 9.92E-08. OF - distance traveled (M): n = 17 WT, n = 16, t(31) = 3.78; p = 0.00067. SA - % alternation: n = 17 WT, t(16) = 1.14;
p = 0.27; n = 16 mutant, t(15) = 1.57; p = 0.14. Ctxl FC - % freezing: n = 13 WT, n = 12 mutant, t(23) = 5.36, p = 0.0000191.
(L)Gad2-Cre: Syngap1+/+ andGad2-Cre: Syngap1+/lx-st mice were subjected to a flurothyl-induced seizure paradigm. Time taken to reach three separate events,
first clonus (1st C), tonic-clonic (T/C), and total hindlimb extension (THE), during the course of the procedure was measured and the two groups compared.
RMANOVA - genotype effect-F(1,23) = 11.69; p = 0.0024; genotype x event interaction-F(2,46) = 0.96; p = 0.39.
WT, blue; mutants, red for all bar graphs. Error bars represent SEM. *p < 0.05, **p < 0.01, ***p < 0.001.
Neuron
Cause of Cognitive Dysfunction in Syngap1 MutantsFinally, we measured mEPSCs from mPFC L2/3 pyramidal
cells in WT, Het, and rescue animals to examine how SynGAP
expression levels in adulthood influence this neurophysiological
disruption that is also present in adult Syngap1 mutants. In
striking contrast to the hippocampal plasticity deficits, elevated
synaptic strength in L2/3 Het pyramidal neurons was not
improved by the adult genetic repair strategy (Figures 8J and
8K). Importantly, we confirmed that the frontal cortices of con-
ventional Syngap1 Hets also have elevated levels of p-ERK1/21326 Neuron 82, 1317–1333, June 18, 2014 ª2014 Elsevier Inc.(Figure S6). Together, these findings support the idea that
enhanced excitatory synaptic strength in superficial cortical
pyramidal cells arises from developmental neuronal damage,
indicating that this neurophysiological disruption is indepen-
dent of homeostatic alterations to Ras/ERK dendritic spine
signaling caused by low SynGAP levels in adult neurons. These
data also further validate the predictive value of enhanced
L2/3 excitatory synaptic strength in Het mice because adult
reversal of pathogenic Syngap1 mutations does not improve
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Cause of Cognitive Dysfunction in Syngap1 Mutantsperformance in behavioral measures of cognition (Clement
et al., 2012).
DISCUSSION
There is a great interest in defining the brain regions and spe-
cific cell types responsible for cognitive deficits in NDDs, with
the hope of developing tailor-made therapies for each specific
condition. Prior studies in other models of NDDs suggest that
cognition and behavioral adaptations are impaired through de-
fects in a wide variety of cell types and circuits. However, not
all cell types expressing the mutation are required to reproduce
important elements of the disorder. For example, deletion
of MECP2 in GABAergic neurons phenotypically mimics the
constitutive germline deletion (Chao et al., 2010), whereas
restoration of gene function in glia provides significant rescue
(Lioy et al., 2011). A similar relationship between GABAergic
neuron dysfunction and NF1 mutations also exists (Cui et al.,
2008). Interestingly, NF1, like Syngap1, is a RasGAP, although
there is a clear distinction between the cell and temporal-spec-
ificity mediated by disruption to these two ID-related genes
(see the Supplemental Experimental Procedures for a detailed
comparison of these two RasGAP-related ID models). Cell
type and brain region specificity has also been extensively
studied in the Tsc1 model, where cerebellar neurons, astro-
cytes, and thalamic excitatory neurons have been implicated
in various behavioral phenotypes (Meikle et al., 2007; Normand
et al., 2013; Tsai et al., 2012; Uhlmann et al., 2002). Although
cortical hyperexcitability results from excitatory neurons in
Fmr1 knockout mice, cell type specificity of cognitive defects
has not been thoroughly examined (Hays et al., 2011). Due to
the robust nature of cognitive deficits in Syngap1+/ mice, we
succeeded in identifying a sensitive cell type (e.g., forebrain
pyramidal neurons) that is both necessary and sufficient
to account for the bulk of the behavioral endophenotype. This
specificity is highlighted by the minimal functional impact of
these mutations in other cell types, such as GABAergic neuronsFigure 6. Enhanced L2/3 Excitatory Synaptic Function Is an Indicator o
(A) Example recordings of mEPSC events from +/+ and +/fl mice obtained by Em
(B) Bar graph and cumulative percentage plots show increased mEPSC amplitud
sample K-S test on cumulative percentage distribution Z = 4.24, p < 0.001).
(C) Bar graph and cumulative percentage plots show increased mEPSC frequen
sample K-S test on cumulative percentage distribution Z = 3.39, p < 0.001).
(D) Example recordings of mEPSC events from +/+ and +/fl mice obtained by Ga
(E) Bar graph and cumulative percentage plots show normal mEPSC amplitude in G
test on cumulative percentage distribution Z = 1.12, p = 0.16).
(F) Bar graph and cumulative percentage plots show normal mEPSC frequency in
K-S test on cumulative percentage distribution Z = 0.69, p = 0.73).
(G) Example recordings of mEPSC events from +/+ and +/lx-st mice obtained by
(H) Bar graph and cumulative percentage plots show normal mEPSC amplitude in
sample K-S test on cumulative percentage distribution Z = 0.62, p = 0.83).
(I) Bar graph and cumulative percentage plots show normal mEPSC frequency in
sample K-S test on cumulative percentage distribution Z = 0.50, p = 0.96).
(J) Example recordings of mEPSC events from +/+ and +/lx-st mice obtained by
(K) Bar graph and cumulative percentage plots show increased mEPSC amplitude
sample K-S test on cumulative percentage distribution Z = 3.86, p < 0.001).
(L) Bar graph and cumulative percentage plots show increased mEPSC frequenc
Two sample K-S test on cumulative percentage distribution Z = 4.34, p < 0.001)
WT, blue; mutants, red for all bar graphs. Error bars represents SEM. *p < 0.05,
1328 Neuron 82, 1317–1333, June 18, 2014 ª2014 Elsevier Inc.located throughout the CNS. In addition to all forebrain pyrami-
dal neurons, the EMX1 driver line used in this study causes
Cre-mediated recombination in glial and Cajal-Retzius cells
(Gorski et al., 2002). Syngap1 is highly enriched in neurons
(Kim et al., 1998). Thus, glia are unlikely to underlie major
aspects of the mouse endophenotype. However, our results
cannot rule out the possibility that other cell types, such as
Cajal-Retzius cells, contribute to cognitive defects in Syngap1
Hets.
Enhanced excitatory synaptic drive onto mature superficial
pyramidal neurons resulting from the developmental impact of
pathogenic Syngap1 mutations may disrupt the computational
power of local synaptic networks by affecting the coding of infor-
mation (Petersen and Crochet, 2013). This idea is supported by
the current findings of abnormal cortical discharges in mature
Syngap1 mutants. Interestingly, similar cortical discharges are
observed in patients with human Syngap1 haploinsufficiency
(Berryer et al., 2013) and the presence of these types of high-
frequency oscillations in humans is associated with reduced
cognition (Nicolai et al., 2012). As a result, even if cellular and/
or network signatures of hyperexcitability cannot be directly
linked to reduced cognition in mature Syngap1+/ mice, the
presence of similar measures of abnormal EEG signals in both
mice and humans with pathogenic Syngap1mutations indicates
the potential for them to serve as a robust endpoint in transla-
tional studies aimed at improving brain function and cognitive
ability in patients.
Our current studies employing temporal and cell type-
specific alterations of SynGAP expression further support
the emerging idea that pathogenic Syngap1 mutations cause
cognitive abnormalities through developmental brain damage
(Clement et al., 2012, 2013). Although we do not know the exact
role of Syngap1 during the developmental critical period, one
possibility is that early synapse maturation caused by patho-
genic disruptions to this gene (Clement et al., 2012, 2013)
may permanently fix the adult spines to a larger size. Indeed,
we have found that newly born spines in the developingf Reduced Cognition in Syngap1 Mutants
x1-Cre x Syngap1+/fl cross. Scale bar represents 20 pA, 100 ms.
e in Emx1-Cre;+/fl mice (n = 10 +/+, n = 12 +/fl, t(20) = 4.92, p = 0.000082; two
cy in Emx1-Cre;+/fl mice (n = 10 +/+, n = 12 +/fl, t(20) = 2.26, p = 0.035; two
d2-Cre x Syngap1+/fl cross. Scale bar represents 20 pA, 100 ms.
ad2-Cre;+/flmice (n = 11 +/+, n = 11 +/fl, t(20) = 0.03, p = 0.98; two sample K-S
in Gad2-Cre;+/fl mice (n = 11 +/+, n = 11 +/fl, t(20) = 0.14, p = 0.89; two sample
Emx1-Cre x Syngap1+/lx-st cross. Scale bar represents 20 pA, 100 ms.
Emx1-Cre;+/lx-st mice (n = 17 +/+, n = 13 +/lx-st, t(28) = 0.00045, p = 0.99; two
in Emx1-Cre;+/lx-st mice (n = 17 +/+, n = 13 +/lx-st, t(28) = 0.68, p = 0.50; two
Gad2-Cre x Syngap1+/lx-st cross. Scale bar represents 20 pA, 100 ms.
in Gad2-Cre;+/lx-st mice (n = 19 +/+, n = 19 +/lx-st, t(36) = 2.49, p = 0.017; two
y in Gad2-Cre;+/lx-st mice (n = 19 +/+, n = 19 +/lx-st, t(36) = 3.15, p = 0.0033.
.
**p < 0.01, ***p < 0.001.
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Cause of Cognitive Dysfunction in Syngap1 MutantsSyngap1 mutant brain are larger than nascent spines born to
WT neurons (M. Aceti and G.R., unpublished data). Dendritic
spine volume is tightly coupled to AMPA receptor function at in-
dividual postsynapses in both the cortex and hippocampus
(Matsuzaki et al., 2001; Noguchi et al., 2011). Thus, abnormally
large spines in mature cortical pyramidal cells in Syngap1 mice
may degrade the ability of these neurons to scale down synap-
tic excitation in response to environmental stimuli or changing
social conditions (Wang et al., 2011). Indeed, according to the
principle of homeostatic regulation of neuronal firing rates (Tur-
rigiano, 2008), excitatory synapses in Syngap1 mutants would
be expected to scale down their strengths to compensate for
the enhanced network excitability that is clearly present in
these mice. Thus, the gradual emergence of elevated excitatory
synaptic function in L2/3 neurons as a secondary consequence
of Syngap1 disruption in development is representative of an
altered form of synaptic homeostasis that degrades the ability
of mature L2/3 neurons to optimally balance excitation relative
to inhibition.EXPERIMENTAL PROCEDURES
The generation of conventional Syngap1+/ mice (Kim et al., 2003), condi-
tional knockout line (Syngap1+/fl), and conditional rescue line (Syngap1+/
lx-st) has been described previously (Clement et al., 2012). All Syngap1
mice are maintained on a BL6/B129sv/ev hybrid background as previously
described (Clement et al., 2012; Guo et al., 2009). Emx1-Cre (#05628),
Gad2-Cre (#10802), PV-Cre (#8069), Inducible CAG-Cre-ERt (#004682),
TdTomato Ai9 (#007905), and GIN-GFP (#03718) lines were purchased from
Jackson Laboratories. According to the supplier, these lines are maintained
on a pure C57/BL6j background (n > 5 generations), except for the PV-Cre
line, which is on a hybrid B6;129p2 background, and the GIN-GFP line, which
is on a FVB/NJ background. In general, male Cre drivers were used in mating
schemes, except for EMX1-ires-Cre crosses, due to rare occurrences of Cre
activity in sperm cells. Video EEG recordings lasted for 2 weeks and random
samples of the recordings were analyzed for evidence of spiking. VSD imagingFigure 7. Global Induction of Syngap1 Haploinsufficiency in Adulthood
(A) Experimental strategy to induce Syngap1 haploinsufficiency during adulthoo
mice, the following four groups of mice were generated and used for experim
Syngap1+/fl. All animals were injected with tamoxifen at 8 weeks of age.
(B) Hippocampal (HPC) tissue was dissected from Cre()/Syngap1+/+, Cre() /S
western blot analysis of SynGAP protein levels normalized to b-tubulin after behav
n = 5 WT, n = 6 mutant, t(9) = 0.44; p = 0.66; Cre(+): n = 7 WT, n = 7 mutant, t(12
(C) Cumulative percentage plots and example recordings show normal mEPSC am
amplitudes 12.59 ± 0.48 +/+, 12.83 ± 0.35 +/fl, t(20) = 0.40, p = 0.69; mean mEP
sample K-S test on cumulative percentage distributions: Z = 1.07, p = 0.2 for mE
(D) Cumulative percentage plots and example recordings show normal mEPSC am
amplitudes 13.04 ± 0.24 +/+, 12.67 ± 0.47 +/fl; mean mEPSC frequencies 12.33
sample K-S test on cumulative percentage distributions Z = 1.28, p = 0.07 for m
(E–H) Cre()/Syngap1+/+, Cre()/Syngap1+/fl, Cre(+)/Syngap1+/+, Cre(+)/Syngap1
task (EPM), an open field test (OFT), an unforced discrete two-trial spontaneous
t tests were performed for EPM, OF, and Ctxl FC tests. One-sample t test with 50
EPM -%Open arm duration - Cre(): n = 15WT, n = 18mutant, t(31) = 0.16, p = 0.8
(M) - Cre():n = 15 WT, n = 16 mutant, t(29) = 0.55, p = 0.59; Cre(+): n = 16 WT,
t(12) = 2.63, p = 0.022; Cre()/Syngap1+/fl: t(14) = 3.21, p = 0.0062; Cre(+)/Syngap
% freezing: Cre(): n = 11 WT, n = 11 mutant, t(20) = 0.83, p = 0.41. Cre(+):n = 1
(I and J) Cre()/Syngap1+/+, Cre()/Syngap1+/fl, Cre(+)/Syngap1+/+, Cre(+)/Synga
to reach three separate events, first clonus (1st C), tonic-clonic (T/C), and total hin
WT and HET groups compared within each of the Cre() and Cre(+) groups. RM
interaction-F(2,50) = 0.66; p = 0.52. Cre(+): genotype effect-F(1,22) = 4.58; p = 0
WT, blue; mutants, red for all bar graphs. Error bars represent SEM. *p < 0.05, **
1330 Neuron 82, 1317–1333, June 18, 2014 ª2014 Elsevier Inc.in cortical slices was performed as previously described (Clement et al., 2012;
Xu et al., 2010). mPFC slices for whole cell electrophysiology experiments
were prepared as described elsewhere (Clement et al., 2013). Behavioral par-
adigms, tamoxifen injections, and fluorothyl-induced seizure protocol were
carried out as described previously (Clement et al., 2012). Extracellular slice
physiology and fluorescence deconvolution tomography has been described
in detail elsewhere (Babayan et al., 2012; Chen et al., 2007, 2010; Vogel-Cier-
nia et al., 2013). All proposed animal research was approved by the TSRI
Animal Care and Use Committee and the studies were subsequently overseen
by this office. For precise details pertaining to all experimental procedures
used in this in this study, please refer to the Supplemental Experimental
Procedures.
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and Treatment.Has a Minimal Impact on L2/3 Synaptic Function and Behavior
d. Following a cross between Syngap1+/fl and hemizygous CreERt transgenic
ents: Cre()/Syngap1+/+, Cre()/Syngap1+/fl, Cre(+)/Syngap1+/+, and Cre(+)/
yngap1+/fl, Cre(+)/Syngap1+/+, and Cre(+)/Syngap1+/fl mice and processed for
ioral and seizure paradigm testing. Normalized density - unpaired t test - Cre():
) = 6.86; p = 0.00000174.
plitude and frequency in (Cre) animals. (n = 11 +/+, n = 11 +/fl; mean mEPSC
SC frequencies 10.14 ± 1.07 +/+, 11.25 ± 0.65 +/fl, t(20) = 0.89, p = 0.38; two
PSC amplitude; Z = 1.02, p = 0.25 for mEPSC interevent interval).
plitude and frequency in (Cre+) animals. (n = 12 +/+, n = 12 +/fl; mean mEPSC
± 0.67 +/+, 12.08 ± 0.74 +/fl, t(22) = 0.70, p = 0.49; t(22) = 0.25, p = 0.80; two
EPSC amplitude; Z = 0.59, p = 0.88 for mEPSC interevent interval).
+/fl mice were run in a behavioral battery consisting of an elevated plus maze
alternation task (SA), and a contextual fear conditioning paradigm. Unpaired
% chance level as hypothetical mean were performed with each group for SA.
7; Cre(+):n = 16WT, n = 17mutant, t(31) = 0.68, p = 0.50. OF - distance traveled
n = 17 mutant, t(31) = 1.40, p = 0.17. SA - % alternation - Cre()/Syngap1+/+:
1+/+: t(15) = 2.42, p = 0.028; Cre(+)/Syngap1+/fl: t(12) = 2.92, p = 0.013. Ctxl FC -
3 WT, n = 9 mutant, t(20) = 0.4, p = 0.69.
p1+/fl mice were subjected to a flurothyl-induced seizure paradigm. Time taken
dlimb extension (THE), during the course of the procedure were measured and
ANOVA – Cre(): genotype effect-F(1,25) = 0.22; p = 0.64; genotype x event
.044; genotype x event interaction-F(2,44) = 2.18; p = 0.12.
p < 0.01, ***p < 0.001.
(legend on next page)
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